May 3, 2020 / 11:33 PM / a month ago

BRIEF-Shanghai Junshi Biosciences Enters Agreement With Eli Lilly And Company

May 4 (Reuters) - Shanghai Junshi Biosciences Co Ltd :

* ENTERED RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH ELI LILLY AND COMPANY

* PARTIES WILL COLLABORATE IN RESEARCH RELATING TO SARS-COV-2 NEUTRALIZING ANTIBODIES

* LILLY GRANTED EXCLUSIVE LICENSE TO MAKE & SELL JUNSHI SARS-COV-2 ANTIBODIES OUTSIDE OF GREATER CHINA

* LILLY WILL PAY TO CO UPFRONT FEE OF US$10 MILLION

* UPON ACHIEVING PRESCRIBED MILESTONE EVENTS, MILESTONE PAYMENTS OF UP TO US$245 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below